
Antibody-Based Immunotherapy for Alzheimer’s Disease
by Jalwa Afroz The antibody aducanumab reduces amyloid-β plaques, helping to prevent the cognitive decline of Alzheimer’s disease. Alzheimer’s disease (AD) is a chronic type of dementia that affects a person’s memory and behavior. Ultimately, cognitive decline and behavioral disturbances lead to a person’s inability to perform daily activity. Through pathophysiological evidence, researchers have shown that amyloid-β (Aβ) plaque buildup in the brain causes neurotoxicity. … Continue reading Antibody-Based Immunotherapy for Alzheimer’s Disease